|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4196 | (2006.01) |
| C07D 249/08 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2135608 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09170772.9 |
| Date of filing the European patent application | 2005-08-25 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2011-10-12 |
| (46) | Date of publication of the claims translation | 2012-02-27 |
| (30) | Number | Date | Country code |
| 20040604219P | 2004-08-25 | US | |
| 20040604220P | 2004-08-25 | US | |
| 20050686351P | 2005-05-31 | US |
| (72) |
Girardet, Jean-Luc, US
Koh, Yung-Hyo, US
|
| (73) |
Ardea Biosciences, Inc.,
4939 Directors Place, San Diego, CA 92121,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | S-triazolil alfa-merkaptoacetanilidai kaip ŽIV atvirkštinės transkriptazės inhibitoriai |
| S-triazolyl alpha -mercaptoacetanilides as inhibitors of HIV reverse transcriptase |
| Payment date | Validity (years) | Amount | |
| 2019-07-31 | 15 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-08-25 |